Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherNEUROPHARMACOLOGY

S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 148-161;
Mark J. Millan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Hjorth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosario Samanin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudy Schreiber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Jaffard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte De Ladonchamps
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Veiga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Goument
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Louis Peglion
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Spedding
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricette Brocco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 282 no. 1 148-161
PubMed 
9223550

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received March 19, 1996
  • Accepted March 10, 1997
  • Published online July 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Mark J. Millan1,
  2. Stephan Hjorth3,
  3. Rosario Samanin,
  4. Rudy Schreiber1,1,
  5. Robert Jaffard2,
  6. Brigitte De Ladonchamps1,
  7. Sylvie Veiga1,
  8. Bertrand Goument1,
  9. Jean-Louis Peglion1,
  10. Michael Spedding1 and
  11. Mauricette Brocco1
  1. 1Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, Croissy-sur-Seine, France (M.J.M., R.Schreiber, B.D.L., S.V., B.G., J.-L.P., M.S., M.B.), 2Psychology Department, University Bordeaux I, Avenue des Facultés 33405, Talence Cedex, France (R.J.), 3Department of Pharmacology, University of Göteborg, Medicinareg, 7, Göteborg, Sweden (S.H.) and 4Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy (R.Samanin)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: January 1999 to April 2022

    AbstractFullPdf
    Jan 1999120
    Feb 19992110
    Mar 1999010
    Apr 1999262
    Jun 1999041
    Jul 1999021
    Aug 1999100
    Sep 1999301
    Oct 1999073
    Nov 1999040
    Dec 1999131
    Feb 2000141
    Apr 2000101
    May 2000265
    Jun 2000125
    Jul 2000033
    Aug 2000037
    Sep 2000201
    Oct 2000275
    Nov 2000239
    Dec 2000112
    Jan 2001087
    Feb 2001142
    Mar 2001155
    Apr 2001233
    May 2001322
    Jun 2001124
    Jul 2001026
    Aug 2001022
    Sep 2001001
    Oct 20012511
    Nov 2001113
    Dec 2001042
    Jan 200201112
    Feb 2002153
    Mar 2002226
    Apr 2002132
    May 2002087
    Jun 2002144
    Jul 2002265
    Aug 2002145
    Sep 2002056
    Oct 2002245
    Nov 20021611
    Dec 2002254
    Jan 2003212
    Feb 20031128
    Mar 2003144
    Apr 2003196
    May 2003172
    Jun 2003011
    Jul 200310154
    Aug 200317193
    Sep 200311238
    Oct 200312211
    Nov 200373112
    Dec 2003102310
    Jan 200420238
    Feb 200416242
    Mar 200421284
    Apr 2004145011
    May 200415425
    Jun 200426379
    Jul 2004285112
    Aug 2004173411
    Sep 20048312
    Oct 20049314
    Nov 20044295
    Dec 20046285
    Jan 200510427
    Feb 200593012
    Mar 200512214
    Apr 20054549
    May 20053235
    Jun 200511213
    Jul 20054227
    Aug 20053182
    Sep 20054246
    Oct 20053524
    Nov 20057336
    Dec 20055121
    Jan 20060226
    Feb 20067287
    Mar 20065154
    Apr 2006898
    May 20061125
    Jun 200601113
    Jul 2006261
    Aug 2006153
    Sep 20068195
    Oct 20068201
    Nov 20064185
    Dec 2006291
    Jan 20078153
    Feb 20072209
    Mar 2007746
    Apr 20077229
    May 20071147
    Jun 20073118
    Jul 20074143
    Aug 2007484
    Sep 20071132
    Oct 20072179
    Nov 200711611
    Dec 2007044
    Jan 2008132
    Feb 2008187
    Mar 20082104
    Apr 20080105
    May 20085124
    Jun 20082224
    Jul 20086138
    Aug 20088126
    Sep 20081644
    Oct 20081273
    Nov 20085127
    Dec 2008352
    Jan 2009221
    Feb 2009631
    Mar 2009152
    Apr 2009221
    May 2009344
    Jun 2009352
    Jul 2009142
    Aug 2009152
    Sep 2009563
    Oct 20091087
    Nov 2009313
    Dec 2009743
    Jan 2010487
    Feb 2010722
    Mar 2010441
    Apr 2010461
    May 2010223
    Jun 2010685
    Jul 20101005
    Aug 2010142
    Sep 2010075
    Oct 20102143
    Nov 2010261
    Dec 20104104
    Jan 2011851
    Feb 2011281
    Mar 2011693
    Apr 2011375
    May 201111135
    Jun 201131013
    Jul 2011976
    Aug 2011587
    Sep 2011364
    Oct 20114154
    Nov 2011786
    Dec 2011355
    Jan 20126105
    Feb 2012654
    Mar 20121287
    Apr 2012453
    May 20125710
    Jun 20123136
    Jul 20125103
    Aug 2012658
    Sep 2012253
    Oct 2012764
    Nov 20126814
    Dec 20128119
    Jan 2013797
    Feb 2013483
    Mar 201371529
    Apr 201371521
    May 2013994
    Jun 2013143
    Jul 20130105
    Aug 2013350
    Sep 20131331
    Oct 2013462
    Nov 2013374
    Dec 2013132
    Jan 2014722
    Feb 2014172
    Mar 2014463
    Apr 20140114
    May 2014236
    Jun 2014235
    Jul 2014631
    Aug 2014230
    Sep 2014940
    Oct 2014133
    Nov 2014424
    Dec 2014243
    Jan 2015422
    Feb 20151113
    Mar 2015983
    Apr 2015633
    May 2015622
    Jun 20153102
    Jul 20154104
    Aug 2015223
    Sep 2015521
    Oct 2015260
    Nov 2015242
    Dec 2015330
    Jan 2016146
    Feb 2016202
    Mar 201642516
    Apr 20164127
    May 2016028
    Jun 2016235
    Jul 2016047
    Aug 2016139
    Sep 2016499
    Oct 2016183
    Nov 20160124
    Dec 2016040
    Jan 2017310
    Feb 20170110
    Mar 2017162
    Apr 2017020
    May 2017042
    Jun 2017071
    Jul 2017040
    Aug 2017061
    Sep 2017164
    Oct 2017060
    Nov 20170114
    Dec 2017044
    Jan 2018071
    Feb 2018233
    Mar 2018071
    Apr 20180103
    May 2018294
    Jun 2018091
    Jul 20180104
    Aug 2018061
    Sep 2018010
    Oct 2018022
    Nov 2018034
    Dec 20181482
    Jan 2019400
    Feb 2019800
    Mar 2019202
    Apr 2019200
    May 2019800
    Jun 2019202
    Jul 2019100
    Aug 2019400
    Sep 20191200
    Oct 20191820
    Nov 20191630
    Dec 2019511
    Jan 2020521
    Feb 2020712
    Mar 2020210
    Apr 2020311
    May 2020300
    Jun 2020022
    Jul 2020300
    Aug 2020503
    Sep 2020210
    Oct 2020900
    Nov 2020734
    Dec 20201430
    Jan 20211180
    Feb 20211282
    Mar 2021761
    Apr 20211310
    May 20212240
    Jun 2021040
    Jul 2021800
    Aug 2021690
    Sep 20211110
    Oct 2021600
    Nov 20211410
    Dec 20211940
    Jan 2022410
    Feb 2022520
    Mar 2022310
    Apr 2022810

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 282, Issue 1
    1 Jul 1997
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    OtherNEUROPHARMACOLOGY

    S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

    Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
    Journal of Pharmacology and Experimental Therapeutics July 1, 1997, 282 (1) 148-161;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    OtherNEUROPHARMACOLOGY

    S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

    Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
    Journal of Pharmacology and Experimental Therapeutics July 1, 1997, 282 (1) 148-161;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
    • Rescue Pharmacology on Disease-Related GRIN Variants
    • Obesity thwarts preconditioning in TBI
    Show more Neuropharmacology

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics